Jonathan Lucas
Biographic Data
| ID | 6764982 |
|---|---|
| NAME | Jonathan Lucas |
| GIVEN NAMES | Jonathan |
| FAMILY NAME | Lucas |
| SIGNATURE | LUCAS J |
| AFFILIATIONS | Family Health International 360 |
| VERIFIED | No |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
A latent trajectory analysis of young sexual and gender minorities’ adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial)
NCT03671239 (14/09/2018)
HIV risk perception and sexual behavior among HIV-uninfected men and transgender women who have sex with men in sub-Saharan Africa
There remains a limited understanding of how men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa (SSA) perceive their risk for HIV and how risk influences behavior during sexual interactions. We performed thematic analysis on in-depth interviews from the qualitative sub-study of HPTN 075 in Kenya, Malawi, and South Africa. Using the Integrated Behavioral Model (IBM) constructs, we found that most MSM and TGW perceive…
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
BACKGROUND: Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection. METHODS: We conducted a randomized, double-blind, double-dummy, noninferiority trial to compare long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) at a dose of 600 mg, given intramuscularly every 8 …
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
Development of a Black Caucus within the HIV Prevention Trials Network (HPTN)
Black men who have sex with men (MSM) have disproportionate HIV disease burden in the United States. Black MSM have been underrepresented in biomedical research, including HIV clinical trials, due to a myriad of socio-structural, socio-cultural, and psychosocial factors. The HIV Prevention Trials Network (HPTN) 061, a feasibility study of a multi-component HIV prevention intervention for Black MSM in six US cities, incorporated the development an…
Building Partnerships and Stakeholder Relationships for HIV Prevention
Building Partnerships and Stakeholder Relationships for HIV Prevention:Longitudinal Cohort Study Focuses on Community Engagement Rondalya D. DeShields, MSN, RN, Jonathan Paul Lucas, MPH, Melissa Turner, MSW, LICSW, Kemi Amola, PhD, Valarie Hunter, Stephanie Lykes, MPH, Anne M. Rompalo, MD, ScM, Sten H. Vermund, MD, Suzanne Fischer, MA, and Danielle F. Haley, MPH, PhD What Is the Purpose of This Study? • HIV Prevention Trials Network 064 assessed …
Building Partnerships and Stakeholder Relationships for HIV Prevention
The COPR model maximized inclusiveness and participation of African American women impacted by HIV, supported recruitment and retention, and was the cornerstone of community engagement
Building Partnerships and Stakeholder Relationships for HIV Prevention
The COPR model maximized inclusiveness and participation of African American women impacted by HIV, supported recruitment and retention, and was the cornerstone of community engagement
Development of a Black Caucus within the HIV Prevention Trials Network (HPTN)
Black men who have sex with men (MSM) have disproportionate HIV disease burden in the United States. Black MSM have been underrepresented in biomedical research, including HIV clinical trials, due to a myriad of socio-structural, socio-cultural, and psychosocial factors. The HIV Prevention Trials Network (HPTN) 061, a feasibility study of a multi-component HIV prevention intervention for Black MSM in six US cities, incorporated the development an…
Building Partnerships and Stakeholder Relationships for HIV Prevention
Building Partnerships and Stakeholder Relationships for HIV Prevention:Longitudinal Cohort Study Focuses on Community Engagement Rondalya D. DeShields, MSN, RN, Jonathan Paul Lucas, MPH, Melissa Turner, MSW, LICSW, Kemi Amola, PhD, Valarie Hunter, Stephanie Lykes, MPH, Anne M. Rompalo, MD, ScM, Sten H. Vermund, MD, Suzanne Fischer, MA, and Danielle F. Haley, MPH, PhD What Is the Purpose of This Study? • HIV Prevention Trials Network 064 assessed …
Building Partnerships and Stakeholder Relationships for HIV Prevention
The COPR model maximized inclusiveness and participation of African American women impacted by HIV, supported recruitment and retention, and was the cornerstone of community engagement
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
BACKGROUND: Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection. METHODS: We conducted a randomized, double-blind, double-dummy, noninferiority trial to compare long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) at a dose of 600 mg, given intramuscularly every 8 …
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
HIV risk perception and sexual behavior among HIV-uninfected men and transgender women who have sex with men in sub-Saharan Africa
There remains a limited understanding of how men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa (SSA) perceive their risk for HIV and how risk influences behavior during sexual interactions. We performed thematic analysis on in-depth interviews from the qualitative sub-study of HPTN 075 in Kenya, Malawi, and South Africa. Using the Integrated Behavioral Model (IBM) constructs, we found that most MSM and TGW perceive…
A latent trajectory analysis of young sexual and gender minorities’ adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial)
NCT03671239 (14/09/2018)
Medicine (7 works) · HIV/AIDS Research and Interventions (6 works) · Family medicine (5 works) · Environmental health (4 works) · HIV, Drug Use, Sexual Risk (4 works) · Human immunodeficiency virus (HIV (4 works) · Community-based participatory research (3 works) · Men who have sex with men (3 works) · Participatory action research (3 works) · Political science (3 works)